Washington Update PACT Medical Device Group March 7, 2013 Mark Leahey

Slides:



Advertisements
Similar presentations
How to Explain Device Reimbursement to your CEO The Medical Device Regulatory and Compliance Congress Barbara J. Calvert March 29, 2006.
Advertisements

THE COMMONWEALTH FUND Developing Innovative Payment Approaches: Finding the Path to High Performance Stuart Guterman Vice President, Payment and System.
Paul B. Ginsburg, Ph.D. Presentation to The Rising Costs of Health Care: What Can be Done, Alliance for Health Reform, June 12, 2012 Policy Support for.
Containing Health Care Costs: Market Forces and Regulation Paul B. Ginsburg, Ph.D. Center for Studying Health System Change and National Institute for.
EMPOWERING PHYSICIANS TO DELIVER THE BEST PATIENT CARE Slides courtesy of: Richard W. Waguespack, MD, FACS President Elect, AAO-HNS, Former CPT Editorial.
1 WHAT IT MEANS FOR YOU? April Health Access is the leading voice for health care consumers in California. Founded in 1987, Health Access is the.
Truven Health Analytics State Exchanges - Data Collection & Analysis April 2014.
Tracey Moorhead President and CEO May 15, 2015 No Disclosures ©AAHCM.
What Wonders Have They Wrought? The Patient Protection and Affordable Care Act.
 2005 Amegy Bank N.A. Member FDIC. Tax-Advantaged Account Solutions HSA, FSA, DCAP, HRA and How they Impact the Bottom-line  2010 Amegy Bank N.A. Member.
Source: New Jersey Hospital Association Copyright 2010, New Jersey Hospital Association Health Reform and New Jersey Sally Roslow
The Value of a National Enrollment Database Eric A. Flowers, MBA July 8, 2013 v1.0.
Issues and Challenges Facing Medicare Mark L. Hayes.
American Society of Anesthesiologists Political Action Committee (ASAPAC ) Resident Recruitment.
Enhancing the capacity of Community-Funded Safety Net Clinics (CSNCs) and Rural Health Clinics (RHCs) to serve medially vulnerable Coloradans. COHBE Outreach.
Because your patients come first. Regulatory and Practice Management Services Daniel L. Johnson, CPC, CPC-H.
Specialty Practice Pathologist Patient cap.org v. # Advocacy Workshop for Engaged Pathologists Mike Giuliani, Senior Director, Legislation and Political.
AAHAM Spring Meeting MHA UPDATE March 15, 2013 Anne Hubbard, Assistant Vice President, Financial Policy & Advocacy 1.
What HIT Policy Changes Will Mean for MedTech October 22, 2004 Blair Childs Executive Vice President, Strategic Planning & Implementation.
Quality/Cost Imperative
Challenges of Health Care Reform New England Society of Healthcare Materials Management September 12, 2008.
PATIENT CARE NETWORK OF OKLAHOMA (PCNOK) Oklahoma Healthcare Authority ABD Care Coordination RFI Response August 17, 2015.
Payment Reform Update: Value Over Volume Amy Mullins, MD, CPE, FAAFP.
The Changing Landscape of Healthcare. Important Terms ACO: Accountable care Organization- group of healthcare providers that agree to be accountable for.
Merit-Based Incentives Advocacy Leadership to Shape Change.
HFMA – Physician Perspective on Key Issues April 5, 2013.
Emerging Payment Models In Response To Purchaser Needs Or What Happens When Folks Are Fed Up François de Brantes Executive Director Health Care Incentives.
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is a bipartisan legislation signed into law on April 16,  Repeals the flawed Sustainable.
NAAG Presidential Initiative Challenges in Health Care Cost, Competition and Policy Innovation Attorney General George Jepsen.
Transforming Healthcare Presentation to the Academy on Violence and Abuse Joe Mott, MBA, FACHE Vice President – Healthcare Transformation April 2013.
HCA 497 MART Experience Tradition /hca497mart.com FOR MORE CLASSES VISIT
Health Care Division Strategic Planning
Summary Projected Business Landscape Physician Employment's Role
Wireless Access SSID: cwag2017
The New Generation Product Briefing
MEDICAL REVIEW, PROGRAM INTEGRITY
Post Acute Care in the Changing Health Care Landscape
Clinical Medical Assisting
Change in Washington… Is seismic
Wireless Access SSID: cwag2017
One Approach to Bundled Payments
Grants Management Update DATA / FFATA
U.S. FDA Center for Devices and Radiological Health Update
Washington Update PACT Medical Device Group March 7, 2013 Mark Leahey
Managing Antitrust Risks in
Thomas B. Valuck, MD, JD Medical Officer & Senior Adviser
FDA’s IDE Decisions and Communications
Chapter 17 Public Policymaking and Budgeting
Executive Overview.
Issues and Challenges Facing Medicare
The Path to Provider Status
Health Reform Implementation: When Sausage-Making Moves Downtown
American Clinical Laboratory Association
FDA-CDRH in the Next Decade A Vision for Change
Medtech in Transition: Where Are We Now and What Lies Ahead
Integrated Health Services Coordination & Delivery
The Physician Payments Sunshine Act
Health Care Reform in America
A Recap of the 2017 National Orthopaedic Leadership Conference
Introduction to TransCelerate
Making Healthcare Affordable
September 7, 2018 Courtney Baird, MS
A Recap of the 2017 National Orthopaedic Leadership Conference
Introduction to TransCelerate
Presentation Overview
An Introduction to the Sunshine Act
Pharmacy – Fully Insured versus Self Funding
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
A Journey Together: New Maryland Healthcare Landscape
RIBGH 2019 Healthcare Summit Kim Keck President & CEO
Presentation transcript:

Washington Update PACT Medical Device Group March 7, 2013 Mark Leahey President & CEO Medical Device Manufacturers Association (MDMA)

About MDMA Founded in 1992 by handful of smaller medical device executives seeking a voice in Washington Today MDMA represents nearly 300 member companies Leverage collective resources to provide top-tier advocacy and educational assistance to companies Track record of success

The Year Ahead 2013 presents significant opportunities and challenges (ex. device tax repeal, FDASIA implementation, cost of care, value of technology) Your engagement is vital to the success of our efforts Collectively, we will succeed

Agenda FDA ACA Implementation (device tax, Sunshine Law, ACOs) Cost of Care/Value of Technology Other Issues

FDA The past 3 years lead to the MDUFA 3 agreement and FDASIA Total time goals Earlier FDA interaction IDE reform 510(k) Modifications Guidance Other FDA “reforms” Benefit-Risk Guidance Network of Experts Key in 2013 will be FDA execution Monitoring FDA performance 3rd Party assessment

FDA (Cont.) UDI Implementation Likely phased in over the next 2-5 years Enhanced Focus on Post-Market Surveillance Potential expansion of De Novo Process Congressional oversight likely to continue

ACA Device Tax Physician Payment Sunshine ACOs & Bundling Continue to push for full repeal in 2013 Bipartisan, bicameral bills introduced last month Explore variety of vehicles for repeal Leverage increasing bipartisan support Will require your input to succeed Physician Payment Sunshine CMS recently issued final regulations Companies must start tracking payments on August 1, 2013 First reports due to CMS by March 31, 2014 ACOs & Bundling Additional ACOs being announced around the country CMS Innovation Center continuing research and testing of bundled payments for episodes of care

The BIG ISSUE - Entitlements 1962 = 14 cents of every federal dollar not going to interest payments spent on entitlement programs Today = 47 cents of every dollar 2030 = 61 cents of every noninterest dollar will be spent on entitlements. MEDICARE is the biggest portion of these expenditures The Reality – MASSIVE change is coming

Cost of Care will be Major Battle in 2013 Great macro data demonstrating devices less than 6% of total healthcare spending Device costs increases (<1%) below rate of medical CPI (approx 4%) Medical services increase much more significant driver of increased costs Other groups that are heavily engaging (AHIP, AHA, AMA, etc) 

We Need More Examples of Micro Data Specific examples of how medical technologies save overall costs Less expensive products Shorter hospitalization  Less invasive

We Need More Patient Advocates to Engage You are close to your patients Identify those with compelling message willing to discuss the value of technology Expand geographic footprint beyond your corporate profile

We Need Industry Engagement MDMA members have ALWAYS stepped up on behalf of innovators and patients Some of the biggest threats lie ahead We will succeed if we all actively engage to shape the narrative

Ultimate Objective: Change narrative to:  Medical Technology is the solution to healthcare costs, not the problem

Coverage with Evidence Development (CED) CED is a policy where CMS covers a new medical device used in a clinical trial so more evidence can be developed for CMS to make an informed decision on coverage New guidance in 2013 CMS may use CED more frequently Local Medicare contractors may initiate data-collection conditions No specific guidance on time-lap of when CED ends and Medicare coverage begins, if at all

CPT Coding Reform Ongoing concerns over growing trend of Category III codes, lack of transparency on CPT Editorial Panel Recent AMA Enhancements: New guidelines for specialty societies (March 2012) Allowed earlier and more meaningful engagement during specific CPT code change proposals Additional reforms expected in 2013

Value of Engagement Success on key issues relies upon the collective effort of the industry Association engagement provides an effective and efficient way for you voice to be heard

Questions? Mleahey@medicaldevices.org (202) 354-7171